Suppr超能文献

补体抑制剂Crry的肾小管表达改变会导致缺血/再灌注后补体激活。

Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.

作者信息

Thurman Joshua M, Ljubanović Danica, Royer Pamela A, Kraus Damian M, Molina Hector, Barry Nicholas P, Proctor Gregory, Levi Moshe, Holers V Michael

机构信息

Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.

出版信息

J Clin Invest. 2006 Feb;116(2):357-68. doi: 10.1172/JCI24521. Epub 2006 Jan 26.

Abstract

Ischemia/reperfusion (I/R) of several organs results in complement activation, but the kidney is unique in that activation after I/R occurs only via the alternative pathway. We hypothesized that selective activation of this pathway after renal I/R could occur either because of a loss of complement inhibition or from increased local synthesis of complement factors. We examined the relationship between renal complement activation after I/R and the levels and localization of intrinsic membrane complement inhibitors. We found that loss of polarity of complement receptor 1-related protein y (Crry) in the tubular epithelium preceded activation of the alternative pathway along the basolateral aspect of the tubular cells. Heterozygous gene-targeted mice that expressed lower amounts of Crry were more sensitive to ischemic injury. Furthermore, inhibition of Crry expressed by proximal tubular epithelial cells in vitro resulted in alternative pathway-mediated injury to the cells. Thus, altered expression of a complement inhibitor within the tubular epithelium appears to be a critical factor permitting activation of the alternative pathway of complement after I/R. Increased C3 mRNA and decreased factor H mRNA were also detected in the outer medulla after I/R, suggesting that altered synthesis of these factors might further contribute to complement activation in this location.

摘要

多个器官的缺血/再灌注(I/R)会导致补体激活,但肾脏的独特之处在于,I/R后的激活仅通过替代途径发生。我们推测,肾脏I/R后该途径的选择性激活可能是由于补体抑制作用丧失,或者是补体因子的局部合成增加。我们研究了I/R后肾脏补体激活与内在膜补体抑制剂的水平及定位之间的关系。我们发现,肾小管上皮细胞中补体受体1相关蛋白y(Crry)的极性丧失先于沿肾小管细胞基底外侧的替代途径激活。表达较低量Crry的杂合基因靶向小鼠对缺血性损伤更敏感。此外,体外抑制近端肾小管上皮细胞表达的Crry会导致替代途径介导的细胞损伤。因此,肾小管上皮细胞内补体抑制剂表达的改变似乎是I/R后允许补体替代途径激活的关键因素。I/R后在外髓质中还检测到C3 mRNA增加和因子H mRNA减少,这表明这些因子合成的改变可能进一步促成该部位的补体激活。

相似文献

引用本文的文献

1
Role of intrarenal complement production in kidney transplantation.肾内补体产生在肾移植中的作用。
Clin Kidney J. 2025 May 1;18(5):sfaf135. doi: 10.1093/ckj/sfaf135. eCollection 2025 May.
6
The role of complement in kidney disease.补体在肾脏疾病中的作用。
Nat Rev Nephrol. 2023 Dec;19(12):771-787. doi: 10.1038/s41581-023-00766-1. Epub 2023 Sep 21.
7
Clinical Advances in Kidney Failure: AKI.肾衰竭的临床进展:急性肾损伤
J Clin Med. 2023 Feb 27;12(5):1873. doi: 10.3390/jcm12051873.
8
Complement: The Road Less Traveled.补体:少有人走的路。
J Immunol. 2023 Jan 15;210(2):119-125. doi: 10.4049/jimmunol.2200540.
9
The complement system in pediatric acute kidney injury.补体系统与儿童急性肾损伤。
Pediatr Nephrol. 2023 May;38(5):1411-1425. doi: 10.1007/s00467-022-05755-3. Epub 2022 Oct 6.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验